Ashwani K. Dhingra

1.4k total citations · 1 hit paper
79 papers, 966 citations indexed

About

Ashwani K. Dhingra is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Ashwani K. Dhingra has authored 79 papers receiving a total of 966 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 18 papers in Organic Chemistry and 15 papers in Pharmacology. Recurrent topics in Ashwani K. Dhingra's work include Synthesis and biological activity (13 papers), Computational Drug Discovery Methods (13 papers) and Medicinal Plants and Neuroprotection (9 papers). Ashwani K. Dhingra is often cited by papers focused on Synthesis and biological activity (13 papers), Computational Drug Discovery Methods (13 papers) and Medicinal Plants and Neuroprotection (9 papers). Ashwani K. Dhingra collaborates with scholars based in India, Taiwan and Nepal. Ashwani K. Dhingra's co-authors include Bhawna Chopra, Kanaya Lal Dhar, D.N. Prasad, Ajmer Singh Grewal, Kumar Guarve, Akash Jain, Sanjeev Mittal, Kunal Nepali, Vishal Bhatia and Sandeep Arora and has published in prestigious journals such as SHILAP Revista de lepidopterología, Chemical Physics Letters and European Journal of Medicinal Chemistry.

In The Last Decade

Ashwani K. Dhingra

67 papers receiving 934 citations

Hit Papers

Natural products: A lead for drug discovery and development 2021 2026 2022 2024 2021 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ashwani K. Dhingra India 12 475 175 150 138 133 79 966
Bhawna Chopra India 12 462 1.0× 158 0.9× 150 1.0× 137 1.0× 131 1.0× 64 924
Zabeer Ahmed India 18 364 0.8× 151 0.9× 113 0.8× 218 1.6× 141 1.1× 87 948
Pallavi Mandave India 5 421 0.9× 85 0.5× 108 0.7× 162 1.2× 115 0.9× 7 855
Amit Choudhari India 14 558 1.2× 345 2.0× 148 1.0× 206 1.5× 165 1.2× 25 1.4k
Suvitha Syam Malaysia 14 385 0.8× 268 1.5× 171 1.1× 267 1.9× 146 1.1× 18 999
Trọng Tuấn Đào South Korea 24 709 1.5× 135 0.8× 170 1.1× 230 1.7× 155 1.2× 35 1.2k
Almas Jabeen Pakistan 20 407 0.9× 261 1.5× 187 1.2× 211 1.5× 170 1.3× 101 1.1k
Palesa Pamela Seele South Africa 4 384 0.8× 106 0.6× 125 0.8× 177 1.3× 166 1.2× 5 877
Manasi Deshpande India 5 437 0.9× 83 0.5× 129 0.9× 164 1.2× 137 1.0× 17 975
Dilip M. Mondhe India 20 532 1.1× 343 2.0× 81 0.5× 167 1.2× 180 1.4× 43 1.1k

Countries citing papers authored by Ashwani K. Dhingra

Since Specialization
Citations

This map shows the geographic impact of Ashwani K. Dhingra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashwani K. Dhingra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashwani K. Dhingra more than expected).

Fields of papers citing papers by Ashwani K. Dhingra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashwani K. Dhingra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashwani K. Dhingra. The network helps show where Ashwani K. Dhingra may publish in the future.

Co-authorship network of co-authors of Ashwani K. Dhingra

This figure shows the co-authorship network connecting the top 25 collaborators of Ashwani K. Dhingra. A scholar is included among the top collaborators of Ashwani K. Dhingra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashwani K. Dhingra. Ashwani K. Dhingra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bhatia, Meenakshi, et al.. (2025). Recent Developments in Oral Drug Delivery of Prokinetic Agents: Nanoparticles and Beyond. Current Drug Delivery. 23(2). 125–143. 1 indexed citations
2.
Kaur, Prabhjot, et al.. (2025). Formulation, Development and Evaluation of Effervescent Tablet of Green Tea (Camellia sinensis). Central Nervous System Agents in Medicinal Chemistry. 25(4). 579–590.
3.
Narwal, Smita, et al.. (2025). Plant Endophytes and their Secondary Metabolites: A Source of Bioactive Compounds. PubMed. 18(1). 77–91.
4.
Narwal, Smita, et al.. (2025). Artificial Intelligence in Pharmaceutical Drug Development: Transforming Formulation and Innovation. Current Drug Discovery Technologies. 22.
5.
Narwal, Smita, et al.. (2025). Oxidative Stress in Cardiovascular Diseases: Mechanisms and Exploring Advanced Therapies. Cardiovascular & Hematological Agents in Medicinal Chemistry. 23(3). 183–201.
6.
Garg, Madhukar, et al.. (2024). Decoding Therapeutic Applications of Quercetin: Recent Advancements in Nanotechnological Strategies. Pharmaceutical Nanotechnology. 13(4). 596–617. 1 indexed citations
7.
Grewal, Ajmer Singh, et al.. (2024). Germacrone: A Multi-targeting Sesquiterpene with Promising Anti-cancer and Chronic Disease Applications. Anti-Cancer Agents in Medicinal Chemistry. 24(19). 1396–1406. 1 indexed citations
9.
Dhingra, Ashwani K., Vishal Bhatia, Bhawna Chopra, & Kumar Guarve. (2022). A Review of Clinical Studies Assessing the Therapeutic Efficacy ofEscitalopram: A Step Towards Development. CNS & Neurological Disorders - Drug Targets. 22(1). 41–50. 1 indexed citations
10.
Dhingra, Ashwani K., et al.. (2022). Formulation and Evaluation of Solid Dispersions of Poorly Water-Soluble Drug- Hesperidin. Letters in Applied NanoBioScience. 12(2). 50–50. 6 indexed citations
11.
Chopra, Bhawna & Ashwani K. Dhingra. (2022). Pulegone: An Emerging Oxygenated Cyclic Monoterpene KetoneScaffold Delineating Synthesis, Chemical Reactivity, and Biologicalpotential. PubMed. 18(1). 16–28. 11 indexed citations
12.
Singh, Sukhbir, Ajmer Singh Grewal, Neelam Sharma, et al.. (2022). Recent updates on development of protein-tyrosine phosphatase 1B inhibitors for treatment of diabetes, obesity and related disorders. Bioorganic Chemistry. 121. 105626–105626. 42 indexed citations
13.
Dhingra, Ashwani K., et al.. (2019). Prodrug Approach: An Alternative to Improve Pharmacokinetic Properties. 4(1). 7–7. 4 indexed citations
14.
Dhingra, Ashwani K., et al.. (2018). Natural Anti-Inflammatory Agents: Recent Progress and Future Perspectives. 3(5). 1 indexed citations
15.
Dhingra, Ashwani K., et al.. (2015). Synthesis and biological evaluation of some new quinazolone fused azetidine analogs as potential anti-inflammatory agents. Der pharma chemica. 7(9). 103–109. 1 indexed citations
16.
Chopra, Bhawna, et al.. (2015). Microwave assisted synthesis of some 5-substituted imidazolone analogs as a new class of non purine xanthine oxidase inhibitors.. Der pharma chemica. 7(9). 145–152. 4 indexed citations
17.
Dhingra, Ashwani K., Bhawna Chopra, & Sanjeev Mittal. (2013). Martynia annua L.: A Review on Its Ethnobotany, Phytochemical and Pharmacological Profile. Journal of Pharmacognosy and Phytochemistry. 1(6). 135–140. 9 indexed citations
18.
Chopra, Bhawna, Ashwani K. Dhingra, & Kanaya Lal Dhar. (2013). Psoralea corylifolia L. (Buguchi) — Folklore to modern evidence: Review. Fitoterapia. 90. 44–56. 208 indexed citations
19.
Chopra, Bhawna, et al.. (2010). Synthesis of combretastatin analogues with their potent anticancer activity. International Journal of Research in Pharmaceutical Sciences. 1(4). 414–416. 4 indexed citations
20.
Dhingra, Ashwani K., et al.. (1971). Methylene produced by vacuum ultraviolet photolysis. Energy of the methylene. Chemical Physics Letters. 9(1). 17–18. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026